Facebook
Twitter
LinkedIn
ForwardTitle
Category
Credits
Event date
Cost
- Opioid Use Disorder (OUD)
- Pharmacology
- 10.00 AMA PRA Category 1 Credit™
- 10.00 ANCC
- 10.00 Association of Social Work Boards (ASWB)
$70.00
Morphine and heroin were first synthesized and used medicinally in the nineteenth century, and recreational and illicit use followed. Historically, heroin dependence has been difficult to treat successfully, with poor outcome being attributed to patient characteristics, environmental factors, and the powerful reinforcing effects of the drug. Agonist-replacement therapy was introduced more than 40 years ago and represented a breakthrough in the management of heroin addiction.
- State Mandated Training
- Prescribing: Opioid(s)
- 4.00 AMA PRA Category 1 Credit™
$0.00
As part of ongoing efforts to address the epidemic of opioid overdose deaths, New York State has established educational requirements to raise healthcare provider awareness of the risks associated with prescribing and taking opioid pain medications. This program fulfills the mandate by providing education about state and federal requirements for prescribing controlled substances; pain management; appropriate prescribing; managing acute pain; palliative medicine; prevention, screening and signs of addiction; responses to abuse and addiction; and end of life care.
- Prescribing: Opioid(s)
- 2.00 AMA PRA Category 1 Credit™
- 2.00 ANCC
$30.00
This on-demand course provides an overview for Iowa clinicians of the CDC Clinical Practice Guideline for Prescribing Opioids for Pain — United States, 2022. It is jointly provided by Iowa Medical Society.Iowa Licensure Requirement: The course fulfills Iowa's requirement for clinicians who prescribe opioids (Nurse Practitioners, Physician Assistants/Associates, Physicians) to complete 2 hours of continuing education regarding the CDC Clinical Practice Guideline for Prescribing Opioids for Pain.
- Prescribing: Opioid(s)
- Pain Management: Opioid(s)
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC
$0.00
This module provides an overview of the 2022 Clinical Practice Guideline recommendations intended for clinicians providing pain care, including those prescribing opioids for outpatients with acute, subacute, and chronic pain. You will learn how to apply the recommendations as flexible standards of care to enable patient-centered decision-making, taking into account an individual’s well-being and what may be expected to happen based on their health or medical conditions.WB4701
- Prescribing: Opioid(s)
- Pain Management: Opioid(s)
- Pain Management: Acute
- 1.00 AMA PRA Category 1 Credit™
$0.00
This lecture provides medical professionals with clinical practice guidelines based on the 2022 CDC Clinical Practice Guideline for Prescribing Opioids for Pain. Key topics include: clarification of misapplications from prior CDC opioid prescribing guidelines, highlights health disparities related to pain, considerations of opioids or non-opioid alternative medications, general recommendations for opioid prescribing and continuation of opioid therapy.
- Drug Diversion
- Prescribing: Controlled Substance(s)
- 3.00 AMA PRA Category 1 Credit™
- 3.00 ANCC
$225.00
Prescribing controlled substances for pain and other conditions is a major focus of both the medical community and legislatures throughout the country. The consequences of the use and abuse of controlled substances are frequently in the news. La. R.S. 40:978.3 requires new prescribers of controlled substances to complete a one-time, three-hour continuing education program on best practices for prescribing, drug diversion prevention, and appropriate treatment for addiction prior to licensure from the Board of Pharmacy.
- Opioid Use Disorder (OUD)
- 1.00 AMA PRA Category 1 Credit™
$7.00
Opioid use disorder is a chronic, relapsing disease with physical and psychiatric components. It is associated with economic hardship, social isolation, incarceration, increased rates of blood-borne infections such as HIV and viral hepatitis, adverse pregnancy outcomes, and increased mortality. According to the NIH, there were 80,411 deaths involving an opioid in the US in 2021, more than in any previous year. Several guidelines on the management of opioid use disorder are available; all recommend maintenance pharmacotherapy as the standard of care.
- Pharmacology
- Weight Management
- 15.00 AMA PRA Category 1 Credit™
- 15.00 ANCC
$105.00
Obesity is a chronic, progressive, relapsing, multifactorial disease resulting in metabolic and biomechanical morbidities and premature mortality, and its prevalence has risen to unacceptable levels in the United States and worldwide. Healthy diet, exercise, and behavioral interventions are crucial components of management but are largely unsuccessful in achieving and maintaining weight reduction sufficient to reduce morbidities and prevent premature mortality because the chronic neuroendocrine disease of obesity remains unaddressed.
- Suicide
- 1.00 AMA PRA Category 1 Credit™
$0.00
Suicide is the tenth-leading cause of death in the United States. A systems-level response to suicidal risk assessment within the inpatient healthcare setting can make a major difference in clinical suicide prevention. This course is designed to prepare medical practitioners for patients at any level of suicidality – passive thoughts to severe – by providing evidence-based screening tools, treatment protocols and available resources in daily practice to assess and treat patients at risk for suicide.